HomeNewsBusinessEarningsDishman Pharma eyes over 15% topline growth going forward
Trending Topics
Q2 Results Live
Bharti Airtel Q2 Results
Tata Consumer Q2 Results
Bank of Baroda Q2 Results

Dishman Pharma eyes over 15% topline growth going forward

Managing director of Dishman Pharmaceuticals, JR Vyas expects the topline growth to be 15% or even more going forward. He also added that the bottomline will grow in the second half too.

November 17, 2011 / 16:29 IST
Story continues below Advertisement
Remove Ad

Your browser doesn't support HTML5 video.

During the second quarter FY12, Dishman Pharmaceuticals' revenues grew 26.5% to Rs 269.2 crore. The company

TAGS: #Carbogen Amcis #Chinese unit #Contract Research and Manufacturing Services (CRAMS) #Dishman Netherlands #Dishman Pharmaceuticals #JR Vyas #marketable molecules (MM) business #Results Boardroom #second quarter FY12 #Vitamin D business
first published: Nov 17, 2011 04:05 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin youtube
Trending Topics
Sensex Today Population Census ICICI Prudential AMC IPO GMP Andhra Bus Accident Happy Birthday Rajinikanth Shivraj Patil Small cap stocks Sheikh Hasina Shivangi Singh Gold Price
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.